Abraxis Bioscience, Inc. www.abraxisbio.com

Abraxis' portfolio includes the world's first and only protein-based nanoparticle chemotherapeutic compound. Called nab™ Technology, this revolutionary and proprietary technology is being aggressively investigated for potential use with a broad range of other drug candidates.

Activery Biotech SL www.activery.com

Activery® uses supercritical fluids (SCF) for the design, development and production of novel crystal forms and innovative drug delivery systems. Activery uses emerging nanotechnologies based on SCF to create new medicines and modified active ingredients for pharmaceutical and cosmetic use.

BioDelivery Sciences International www.bdsinternational.com

A specialty pharmaceutical company that is exploiting our licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics.

CombiMatrix Corporation www.combimatrix.com

CombiMatrix's patented electrochemical manufacturing process utilizes standard semiconductor technology, proprietary software, and chemistry to build arrays of materials -- molecule by molecule. The company's CustomArray™ products are DNA microarrays, which have uses in pharmaceutical, biotech, and agrochemical industries as well as in research and government markets.

GeneFluidics, Inc. www.genefluidics.com

GeneFluidics has developed a fast, accurate, and simple testing system for improving worldwide health. By integrating novel bionano and microfluidic technologies, their revolutionary platform will enable complex tests currently performed by skilled technicians in a laboratory to be performed by anyone, anywhere.

Immunicon Corporation www.immunicon.com

Immunicon is developing and commercializing diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer. Our instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells (CTCs) in cancer patients or circulating endothelial cells (CECs), which are elevated in a variety of diseases.

NanoMed Pharmaceuticals, Inc. www.nanomedpharm.com

NanoMed Pharmaceuticals® is an early-stage specialty pharmaceutical company dedicated to developing improved therapeutic and diagnostic products to treat or detect cancer and other serious diseases. The company’s core technology, Nanotemplate Engineering, is a nanoparticle manufacturing technology used to formulate small molecules, peptides, proteins, plasmid DNA, and diagnostic agents.

Spinelix www.spinelix.eu

Spinelix microsystems are applied to biophotonics and clinical diagnostics and therapy, in conjunction with cutting edge public and private research centres in Europe. A close relationship with top Clinical world leaders allows the development of innovative products for the health care of tomorrow.

Submit Your Site